Sheela Foam Ltd

Sheela Foam Ltd

₹ 655 0.28%
21 May 2:36 p.m.
About

Sheela Foam Limited is a leading player in India’s mattress and foam products industry and a leader in Polyurethane (PU) Foam. It has a nationwide presence in manufacturing PU Foam with a track record, since 1971. [1]

Key Points

Largest Manufacturer of Polyurethane Foam
The company is India's largest manufacturer of flexible slab stock Polyutherane (PU) foam and mattresses under Sleepwell, Furlenco, and Kurlon [1] with a 30% market share in India’s mattress segment and a 40% market share in Australia. The Kurlon brand holds a 12-13% market share of the modern mattress market.[2] [3] [4]

  • Market Cap 7,120 Cr.
  • Current Price 655
  • High / Low 1,067 / 618
  • Stock P/E 88.9
  • Book Value 279
  • Dividend Yield 0.00 %
  • ROCE 4.39 %
  • ROE 2.69 %
  • Face Value 5.00

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 10.1% over past five years.
  • Company has a low return on equity of 5.98% over last 3 years.
  • Earnings include an other income of Rs.162 Cr.
  • Promoter holding has decreased over last 3 years: -7.26%
  • Working capital days have increased from 32.3 days to 65.4 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
737 701 722 761 729 645 613 879 845 810 813 967 850
665 635 644 685 651 567 547 803 765 750 743 879 817
Operating Profit 72 66 78 76 78 78 66 76 81 60 69 88 33
OPM % 10% 9% 11% 10% 11% 12% 11% 9% 10% 7% 9% 9% 4%
16 18 23 28 18 13 24 32 70 61 32 7 61
Interest 2 5 5 5 7 8 9 25 27 28 28 29 35
Depreciation 24 21 20 22 26 23 22 30 41 40 48 45 50
Profit before tax 62 58 75 77 63 60 60 53 83 53 25 21 9
Tax % 20% 27% 29% 20% 31% 28% 26% 27% 17% 12% 63% 14% -140%
49 43 54 61 44 43 44 31 65 47 9 19 22
EPS in Rs 5.04 4.31 5.44 6.20 4.43 4.41 4.04 2.83 5.94 4.23 0.90 1.73 1.98
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,221 1,359 1,550 1,680 1,889 2,066 2,121 2,437 2,866 2,873 2,982 3,439
1,136 1,268 1,374 1,484 1,672 1,855 1,821 2,073 2,550 2,575 2,678 3,189
Operating Profit 85 91 176 196 217 211 300 364 315 298 304 250
OPM % 7% 7% 11% 12% 11% 10% 14% 15% 11% 10% 10% 7%
0 11 16 23 21 28 28 50 79 86 136 162
Interest 19 16 12 11 9 10 13 18 17 21 69 121
Depreciation 30 28 29 30 35 40 59 73 81 90 116 183
Profit before tax 36 58 152 178 193 189 256 324 296 273 256 108
Tax % 23% 26% 31% 29% 31% 29% 24% 26% 26% 26% 24% 12%
28 43 105 126 134 134 194 240 219 201 184 97
EPS in Rs 8.57 13.13 32.22 12.86 13.70 13.70 19.82 24.36 22.27 20.39 16.78 8.84
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 10%
5 Years: 10%
3 Years: 6%
TTM: 15%
Compounded Profit Growth
10 Years: 6%
5 Years: -16%
3 Years: -27%
TTM: -42%
Stock Price CAGR
10 Years: %
5 Years: -1%
3 Years: -25%
1 Year: -29%
Return on Equity
10 Years: 13%
5 Years: 9%
3 Years: 6%
Last Year: 3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 16 16 16 24 24 24 24 24 24 49 54 54
Reserves 180 229 322 439 573 706 895 1,160 1,368 1,549 2,866 2,981
188 146 115 59 48 31 310 334 466 571 1,493 1,462
241 289 335 395 398 401 414 551 496 533 909 970
Total Liabilities 625 679 788 918 1,043 1,162 1,644 2,069 2,355 2,702 5,322 5,467
252 286 288 318 348 412 851 894 883 865 3,129 3,155
CWIP 17 8 10 36 52 1 18 33 120 287 166 131
Investments 0 0 10 0 98 318 231 411 618 768 878 873
356 385 481 564 544 432 544 732 734 781 1,150 1,309
Total Assets 625 679 788 918 1,043 1,162 1,644 2,069 2,355 2,702 5,322 5,467

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
124 147 159 122 134 138 157 254 197 218 406 252
-27 -49 -34 2 -80 -246 -287 -208 -306 -272 -2,258 -29
-53 -59 -25 -67 -20 -27 157 -32 93 56 1,854 -226
Net Cash Flow 45 40 100 57 34 -135 27 13 -17 1 2 -3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 36 31 28 30 28 27 37 45 34 36 45 37
Inventory Days 61 52 49 59 60 60 81 87 64 71 73 64
Days Payable 57 57 52 64 51 46 55 91 58 55 83 66
Cash Conversion Cycle 40 26 24 25 37 41 63 41 40 51 34 35
Working Capital Days 19 -3 -10 -4 7 14 28 28 30 25 7 65
ROCE % 14% 19% 38% 39% 35% 28% 26% 23% 18% 14% 8% 4%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
72.95% 72.95% 72.95% 72.95% 72.95% 65.48% 65.48% 65.48% 65.48% 65.48% 65.69% 65.69%
3.11% 3.16% 3.19% 3.26% 3.21% 6.04% 6.12% 6.32% 6.40% 6.60% 6.56% 6.23%
22.84% 22.73% 22.43% 22.28% 21.95% 25.08% 24.99% 24.52% 23.40% 22.30% 21.03% 21.17%
1.10% 1.14% 1.43% 1.50% 1.89% 3.40% 3.40% 3.68% 4.72% 5.62% 6.71% 6.91%
No. of Shareholders 18,23118,94525,29127,23230,57444,13739,44439,10351,04755,95460,35460,089

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls